ATOS
Atossa Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$5.01
-0.04 ▼ -0.79%
🌙 3월 13일 6:52 PM ET (한국 3/14 07:52)
$4.93
-0.08 ▼ -1.60%
| Index | - | P/E | - | EPS (ttm) | -3.52 | Insider Own | 0.31% | Shs Outstand | 0.01B | Perf Week | 10.6% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | 2.3% | Insider Trans | - | Shs Float | 0.01B | Perf Month | 23.7% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -1.14 | Inst Own | 21.44% | Short Float | 4.21% | Perf Quarter | -60.71% |
| Income | -0.03B | P/S | - | EPS this Y | -30.25% | Inst Trans | 1.52% | Short Ratio | 2.49 | Perf Half Y | -59.43% |
| Sales | 0.00B | P/B | 0.87 | EPS next 5Y | -7.05% | ROA | -43.9% | Short Interest | 0.36M | Perf YTD | -43.39% |
| Book/sh | 5.78 | P/C | 0.83 | EPS past 3/5Y | -4.77% 36.92% | ROE | -48.89% | 52W High | -74.11% ($19.35) | Perf Year | -51.27% |
| Cash/sh | 6.03 | P/FCF | - | Sales past 3/5Y | - | ROIC | -60.62% | 52W Low | 33.24% ($3.76) | Perf 3Y | -48.62% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -9.45% | Gross Margin | - | Volatility(W/M) | 7.45% 8.41% | Perf 5Y | -88.52% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.46 | Perf 10Y | -99.42% |
| Dividend Ex-Date | - | Quick Ratio | 6.77 | EPS Q/Q | -17.07% | Profit Margin | - | RSI (14) | 45.6 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 6.77 | Sales Q/Q | - | SMA20 | 11.09% ($4.51) | Beta | 1.42 | Target Price | $63.75 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | -24.8% ($6.66) | Rel Volume | 0.73 | Prev Close | $5.05 |
| Employees | 15 | LT Debt/Eq | 0 | EPS/Sales Surpr. | -7.69% - | SMA200 | -54.76% ($11.07) | Avg Volume(3M) | 0.15M | Price | $5.01 |
| IPO | 2012/11/8 | Option/Short | Yes/Yes | Trades | 613 | Volume | 105,749 | Change | -0.79% |
뉴스 로딩 중...